These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12429069)

  • 1. The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C?
    Baker SG; Kramer BS
    BMC Med Res Methodol; 2002 Nov; 2():13. PubMed ID: 12429069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of the MAGIC study: sufficient for recommendations?
    Bauer K; Porzsolt F; Henne-Bruns D
    Hepatogastroenterology; 2013 Oct; 60(127):1822-4. PubMed ID: 24624448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sequential phase II/III trial for binary outcomes.
    Storer BE
    Stat Med; 1990 Mar; 9(3):229-35. PubMed ID: 2160719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating sample size for a randomized clinical trial of lung cancer screening.
    Obuchowski NA
    Contemp Clin Trials; 2008 Jul; 29(4):466-77. PubMed ID: 18088564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triangular test and randomized trials: practical problems in a small cell lung cancer trial.
    Pignon JP; Tarayre M; Auquier A; Arriagada R; Le Chevalier T; Ruffié P; Rivière A; Monnet I; Chomy P; Tuchais C
    Stat Med; 1994 Jul 15-30; 13(13-14):1415-21. PubMed ID: 7973221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trials, generalizability, and meta-analysis: graphical insights for binary outcomes.
    Baker SG; Kramer BS
    BMC Med Res Methodol; 2003 Jun; 3():10. PubMed ID: 12809566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
    Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
    World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perception, paradox, paradigm: Alice in the wonderland of lung cancer prevention and early detection.
    Strauss GM; Dominioni L
    Cancer; 2000 Dec; 89(11 Suppl):2422-31. PubMed ID: 11147620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simulated sequential analysis based on data from two MRC trials.
    Donaldson AN; Whitehead J; Stephens R; Machin D
    Br J Cancer; 1993 Dec; 68(6):1171-8. PubMed ID: 8260369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastric cancer].
    Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Gotouda N
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):313-7. PubMed ID: 16531710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-agent versus combination chemotherapy in advanced non-small cell lung cancer: a meta-analysis and the Cancer and Leukemia Group B randomized trial.
    Lilenbaum RC; List M; Desch C
    Semin Oncol; 1999 Oct; 26(5 Suppl 15):52-4. PubMed ID: 10566612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simpson's paradox and clinical trials: what you find is not necessarily what you prove.
    Abramson NS; Kelsey SF; Safar P; Sutton-Tyrrell K
    Ann Emerg Med; 1992 Dec; 21(12):1480-2. PubMed ID: 1443848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observational, one-arm studies and randomized population-based trials for evaluation of the efficacy of lung cancer screening.
    Paci E
    J Thorac Oncol; 2007 May; 2(5 Suppl):S45-6. PubMed ID: 17457234
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic therapy beyond first-line in advanced gastric cancer: An overview of the main randomized clinical trials.
    Galdy S; Cella CA; Spada F; Murgioni S; Frezza AM; Ravenda SP; Zampino MG; Fazio N
    Crit Rev Oncol Hematol; 2016 Mar; 99():1-12. PubMed ID: 26697987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perhaps it is time for a change in policy on lung cancer screening.
    Yankelevitz DF
    Cleve Clin J Med; 2007 Jun; 74(6):438-40. PubMed ID: 17569201
    [No Abstract]   [Full Text] [Related]  

  • 16. The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI.
    Al-Batran SE; Goetze TO; Mueller DW; Vogel A; Winkler M; Lorenzen S; Novotny A; Pauligk C; Homann N; Jungbluth T; Reissfelder C; Caca K; Retter S; Horndasch E; Gumpp J; Bolling C; Fuchs KH; Blau W; Padberg W; Pohl M; Wunsch A; Michl P; Mannes F; Schwarzbach M; Schmalenberg H; Hohaus M; Scholz C; Benckert C; Knorrenschild JR; Kanngießer V; Zander T; Alakus H; Hofheinz RD; Roedel C; Shah MA; Sasako M; Lorenz D; Izbicki J; Bechstein WO; Lang H; Moenig SP
    BMC Cancer; 2017 Dec; 17(1):893. PubMed ID: 29282088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer screening: an update.
    Marcus PM
    J Clin Oncol; 2001 Sep; 19(18 Suppl):83S-86S. PubMed ID: 11560979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of adjuvant chemotherapy for gastric cancer.
    Nakajima T
    World J Surg; 1995; 19(4):570-4. PubMed ID: 7676702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
    Okawara G; Rusthoven J; Newman T; Findlay B; Evans W
    Cancer Prev Control; 1997 Aug; 1(3):249-59. PubMed ID: 9765750
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.